BioSpace News Archive

Crucial Data Solutions Release: New Technology Brings EHR Data to the Forefront of Clinical Research

Crucial Data Solutions together with strategic partner Zircon Technologies, announce the official release of a software solution to accelerate the clinical trials process.

December 5, 2017

·

3 min read

Drug Development

Ovid Therapeutics Announces TAK-935/OV935 Has Received Orphan Drug Designation From U.S. FDA for Treatment of Dravet Syndrome

Takeda and Ovid formed a global collaboration to develop and commercialize TAK-935/OV935 for the treatment of developmental and epileptic encephalopathies in January 2017.

December 5, 2017

·

7 min read

Maetrics $16.5B Market Advantage Revealed for Medtech Firms Seizing the MDR Compliance Opportunity

MAETRICS today publishes new research quantifying the competitive advantage that medical device manufacturers can seize by moving quickly to comply with the new European Medical Device Regulation.

December 5, 2017

·

2 min read

Business

Horizon Extends Industry-Leading Gene Editing IP Portfolio Through Expansion of CRISPR License Rights With ERS Genomics

Horizon Pharma and ERS Genomics, today announce the extension of their pre-existing non-exclusive, worldwide license agreement to significantly expand Horizon’s license coverage for the use of the CRISPR gene editing technology.

December 5, 2017

·

2 min read

Lone Star Bio

CorInnova Awarded “2017 InnoSTARS” Prize for its Non-Blood-Contacting, Soft Robotic Heart Assist Device as Alternative to LVADs for Treatment of Heart Failure

The competition provided U.S.-based innovators and companies with a better understanding of the opportunities available to companies interested in doing business in China as well as well as direct interface with qualified Chinese partners and investors.

December 5, 2017

·

4 min read

Philips Wins FDA Nod for Small Parts Ultrasound Tr

FDA

Lia Diagnostics Nabs FDA OK for First and Only Flushable, Biodegradable Pregnancy Test

Lia is the result of years of research that combines the desire for discretion with sustainable materials and novel engineering into a pregnancy test that doesn’t harm the earth.

December 5, 2017

·

3 min read

Pharm Country

Tyme Provides Update on At-The-Market Financing Activity

Between November 6 and December 4, 2017, the Company sold approximately 1.2 million shares of Tyme common stock at an average price of $4.05 per share.

December 5, 2017

·

4 min read

Drug Development

Actinium Pharmaceuticals Unveils Actimab-MDS and Planned Phase II Trial in Myelodysplastic Syndromes Targeted at Patients With High-Risk p53+ Genetic Mutations

Actinium, together with Dr. Roboz, will conduct a webcast at 8 AM ET on December 5, 2017 to introduce Actimab-MDS and the planned Phase 2 trial.

December 5, 2017

·

8 min read

FDA

Sonoma Pharmaceuticals Announces Second FDA Approval to Add Antimicrobial Language to Alevicyn Gel Products for Management of Atopic Dermatitis

Second FDA approval in as many months further validates expanding adoption of Alevicyn products by dermatologists.